FBIO Dividend: Fortress Biotech Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

FBIO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	62	57	84	75	68	45
Revenue Growth (YoY)	0%	-32%	12%	10%	51%	25%
Cost of Revenue	17	20	26	30	32	14
Gross Profit	44	36	57	44	36	31
Selling, General & Admin	108	87	91	113	86	61
Research & Development	22	56	106	134	128	64
Operating Expenses	106	148	197	248	215	125
Other Non Operating Income (Expenses)	17	1	4	1	--	--
Pretax Income	-53	-120	-153	-213	-164	-102
Income Tax Expense	0	0	0	0	0	0
Net Income	-5	-55	-68	-86	-64	-46
Net Income Growth	-91%	-19%	-21%	34%	39%	18%
Shares Outstanding (Diluted)	33.1	20.78	8.11	5.93	5.45	4.8
Shares Change (YoY)	68%	156%	37%	9%	14%	32%
EPS (Diluted)	-0.16	-2.68	-8.46	-14.61	-11.88	-9.69
EPS Growth	-95%	-68%	-42%	23%	23%	-12%
Free Cash Flow	-66	-95	-133	-182	-121	-86
Free Cash Flow Per Share	-1.99	-4.57	-16.39	-30.69	-22.2	-17.91
Gross Margin	70.96%	63.15%	67.85%	58.66%	52.94%	68.88%
Operating Margin	-100%	-194.73%	-165.47%	-270.66%	-263.23%	-208.88%
Profit Margin	-8.06%	-96.49%	-80.95%	-114.66%	-94.11%	-102.22%
Free Cash Flow Margin	-106.45%	-166.66%	-158.33%	-242.66%	-177.94%	-191.11%
EBITDA	-56	-108	-134	-196	-174	-91
EBITDA Margin	-90.32%	-189.47%	-159.52%	-261.33%	-255.88%	-202.22%
D&A For EBITDA	6	3	5	7	5	3
EBIT	-62	-111	-139	-203	-179	-94
EBIT Margin	-100%	-194.73%	-165.47%	-270.66%	-263.23%	-208.88%
Effective Tax Rate	0%	0%	0%	0%	0%	0%